554 filings
Page 5 of 28
CT ORDER
sxb3504 h3u2
31 Mar 14
Confidential treatment order
12:00am
424B5
x0y e4nltkwp
6 Mar 14
Prospectus supplement for primary offering
12:00am
8-K
sli4 y1rrjb0ac6
6 Mar 14
Synageva Biopharma™ Announces a 2.00 Million Share Proposed Public Offering of Its Common Stock
12:00am
424B5
fnsc420
4 Mar 14
Prospectus supplement for primary offering
12:00am
8-K
6rvkd1y28glwp8ga59
3 Mar 14
Synageva Biopharma™ Reports 2013 Full Year Financial Results
12:00am
8-K
9hl7g97q6qvu
26 Feb 14
Entry into a Material Definitive Agreement
12:00am
8-K
vpxuh3zp zsej8rayjm
9 Dec 13
Entry into a Material Definitive Agreement
12:00am
8-K
lw5z3xadjl9v8
29 Oct 13
Synageva Biopharma™ Reports Third Quarter 2013 Financial Results
12:00am
8-K
6k1ux
24 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
rpo o7nemjmxydxukr
25 Sep 13
Synageva BioPharma™ Announces a 2.75 Million Share Proposed Public Offering of its Common Stock
12:00am
424B5
f2afwsbb7cuhfwoow tx
25 Sep 13
Prospectus supplement for primary offering
12:00am
424B5
cxqxj
23 Sep 13
Prospectus supplement for primary offering
12:00am
UPLOAD
gm5j f6en
21 Aug 13
Letter from SEC
12:00am
CORRESP
4p7lbjc ulybyy1ukn
9 Aug 13
Correspondence with SEC
12:00am
8-K
jdgcsldbzmw9f04
5 Aug 13
Synageva Biopharma™ Reports Second Quarter 2013 Financial Results and Announces Appointment of Chief Operating Officer
12:00am